Related Experiment Video
Updated: Dec 13, 2025

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
COVID-19 in patients with heart failure: the new and the old epidemic
Nicolò Sisti1, Serafina Valente2, Giulia Elena Mandoli2
1Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy nic.sisti@gmail.com.
Insights
Patients with heart failure face increased risks from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19). Special care and therapy adjustments are crucial for managing these high-risk cardiovascular patients.
Area of Science:
- Infectious Diseases
- Cardiology
- Critical Care Medicine
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapidly spread globally, causing the coronavirus disease 2019 (COVID-19) pandemic.
- Patients with pre-existing cardiovascular diseases, particularly chronic heart failure, exhibit a high prevalence among COVID-19 cases.
- The combination of COVID-19 and heart failure is associated with a poor prognosis and elevated risk of intensive care unit (ICU) mortality.
Purpose of the Study:
- To highlight the clinical challenges posed by COVID-19 in patients with heart failure.
- To underscore the mechanisms by which SARS-CoV-2 impacts myocardial function and exacerbates heart failure.
- To emphasize the need for specialized care and management strategies for heart failure patients during the COVID-19 pandemic.
Main Methods:
- This study is a review and clinical perspective based on current literature and clinical observations.
- Analysis of the interplay between SARS-CoV-2 infection and cardiovascular pathophysiology in heart failure patients.
- Discussion of potential therapeutic adjustments and monitoring protocols.
Main Results:
- SARS-CoV-2 infection can precipitate myocardial injury and acute decompensation in patients with chronic heart failure.
- The viral infection presents unique challenges, potentially worsening cardiac function through various pathophysiological pathways.
- Effective management requires a re-evaluation of existing medical therapies and vigilant monitoring, especially during ventilatory support.
Conclusions:
- COVID-19 poses a significant threat to patients with heart failure, increasing morbidity and mortality.
- A multidisciplinary approach is essential, involving careful assessment of cardiac status and adaptation of treatment plans.
- Prompt recognition and tailored management are critical for improving outcomes in this vulnerable patient population.
Abstract:
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has spread in nearly 200 countries in less than 4 months since its first identification; accordingly, the coronavirus disease 2019 (COVID 2019) has affirmed itself as a clinical challenge. The prevalence of pre-existing cardiovascular diseases in patients with COVID19 is high and this dreadful combination dictates poor prognosis along with the higher risk of intensive care mortality. In the setting of chronic heart failure, SARS-CoV-2 can be responsible for myocardial injury and acute decompensation through various mechanisms. Given the clinical and epidemiological complexity of COVID-19, patiens with heart failure may require particular care since the viral infection has been identified, considering an adequate re-evaluation of medical therapy and a careful monitoring during ventilation.
More Related Videos
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation

